The European Commission said on Wednesday it had signed a contract on behalf of EU states with U.S. drugmaker Johnson & Johnson for the supply of 400 million doses of its COVID-19 vaccine candidate.
The move follows an advance purchase agreement signed by Brussels with Johnson & Johnson earlier in October.
